Assessing the Safety, Tolerability, Pharmacokinetics, and Biodistribution of Novel Oral Formulations of Amphotericin B following Single- and Multiple-Dose Administration to Beagle Dogs

類似資料

• Safety, Tolerability, and Pharmacokinetics of a Novel Oral Amphotericin B Formulation (iCo-019) following Single-Dose Administration to Healthy Human Subjects: an Alternative Approach to Parenteral Amphotericin B Administration
  著者:: Hnik, Peter, 等
  出版事項: (2020)
• Efficacy, Biodistribution, and Nephrotoxicity of Experimental Amphotericin B-Deoxycholate Formulations for Pulmonary Aspergillosis
  著者:: López-Sánchez, Alicia, 等
  出版事項: (2018)
• Pharmacokinetics of BMEDA after Intravenous Administration in Beagle Dogs
  著者:: Chang, Chih-Hsien, 等
  出版事項: (2014)
• Effects of Lipid-Based Oral Formulations on Plasma and Tissue Amphotericin B Concentrations and Renal Toxicity in Male Rats
  著者:: Risovic, Verica, 等
  出版事項: (2003)
• Physiologically Based Pharmacokinetic Model of Amphotericin B Disposition in Rats Following Administration of Deoxycholate Formulation (Fungizone®): Pooled Analysis of Published Data
  著者:: Kagan, Leonid, 等
  出版事項: (2011)